CVS Health Surges with AI and Wellness | Business and Finance News

CVS Health just smashed Q2 earnings, posting $5.2 billion in adjusted operating income and $2.58 EPS—beating forecasts—and is now raising its full-year guidance by 60 cents to $7.90–$8.10 per share. They’re also boosting their cash flow forecast to at least $11.5 billion. With a laser focus on making healthcare affordable, especially for GLP-1 weight loss drugs, they’re partnering with employers, offering $29 virtual weight management via MinuteClinic, and enabling same-day pickup through Eli Lilly. Their tech push includes launching AI assistant Haio to streamline care for patients and providers, tackling prior authorizations and claims processing. While acknowledging headwinds in pharmacy services from the 340B program and potential membership declines, they’re confident specialty pharmacy and other initiatives will offset these. Overall, CVS is delivering strong growth across segments—from Aetna’s rebound to booming consumer wellness—with a clear vision to leverage tech and integration to drive value for both customers and shareholders. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/150acbe8a3694787